Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?


Currently submitted to: Interactive Journal of Medical Research

Date Submitted: May 29, 2019
Open Peer Review Period: Jun 3, 2019 - Jul 29, 2019
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer-Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Title: A new treatment modality to reduce acute tonsillitis healing time

  • Hüseyin Keskin; 
  • Oğuz Güvenmez


Acute tonsillitis is the most common reason for ear, nose and throat services. The infectious factors of tonsillitis are shown in detail in the studies. in the treatment of acute tonsillitis, supportive therapies are mostly used. As antibiotic therapy; Penicillin V if allergy is given Erythromycin-estolate.


The aim of this study is to accelerate the clinical recovery by providing parenteral treatment and daily cleaning of tonsillar lesions in patients who were admitted to the otolaryngology because of acute tonsillitis.


Patients in the age range 15-60 are included the study. The patients were divided into two groups. To the 1st group i.v. With the combination of ampicillin + sulbactam and i.v clindamycin, the tonsillar membrane was cleaned daily.21 In the second group only i.v. In combination with ampicillin + sulbactam and i.v clindamycin combination.


Patients who received antibiotherapy and debridement had clinical improvement at 90% on day 2 and 95% on 5 days. Only patients receiving antibiotics had a clinical improvement of 65% at day 5 and 75% at day 7. The recovery time of both groups was statistically significant. (P <0.05)


The solution and technique used in this clinical study showed that patients with acute tonsillitis could recover in a very short time without any complications.


Please cite as:

Keskin H, Güvenmez O

Title: A new treatment modality to reduce acute tonsillitis healing time

JMIR Preprints. 29/05/2019:14872

DOI: 10.2196/preprints.14872


Download PDF

Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.